Bath & Body Works, Inc.
Bath & Body Works, Inc. (0JSC.L) Financial Performance & Income Statement Overview
Explore the financials of Bath & Body Works, Inc. (0JSC.L), including yearly and quarterly data on income, cash flow, and balance sheets.
Bath & Body Works, Inc. (0JSC.L) Income Statement & Financial Overview
Explore comprehensive income reports for Bath & Body Works, Inc. 0JSC.L, broken down by year and quarter.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $2.79B | $1.61B | $1.53B | $1.38B |
Cost of Revenue | $1.49B | $910.00M | $900.00M | $778.00M |
Gross Profit | $1.30B | $700.00M | $626.00M | $606.00M |
Gross Profit Ratio | $0.47 | $0.43 | $0.41 | $0.44 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $623.00M | $482.00M | $443.00M | $419.00M |
Operating Expenses | $623.00M | $482.00M | $443.00M | $419.00M |
Total Costs & Expenses | $2.11B | $1.39B | $1.34B | $1.20B |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $76.00M | $77.00M | $77.00M | $82.00M |
Depreciation & Amortization | $71.00M | $69.00M | $71.00M | $71.00M |
EBITDA | $759.00M | $291.00M | $254.00M | $258.00M |
EBITDA Ratio | $0.27 | $0.18 | $0.17 | $0.19 |
Operating Income | $678.00M | $218.00M | $183.00M | $187.00M |
Operating Income Ratio | $0.24 | $0.14 | $0.12 | $0.14 |
Other Income/Expenses (Net) | -$67.00M | -$73.00M | -$30.00M | -$69.00M |
Income Before Tax | $611.00M | $145.00M | $153.00M | $118.00M |
Income Before Tax Ratio | $0.22 | $0.09 | $0.10 | $0.09 |
Income Tax Expense | $158.00M | $39.00M | $1.00M | $31.00M |
Net Income | $453.00M | $106.00M | $152.00M | $87.00M |
Net Income Ratio | $0.16 | $0.07 | $0.10 | $0.06 |
EPS | $2.10 | $0.49 | $0.68 | $0.39 |
Diluted EPS | $2.09 | $0.48 | $0.68 | $0.39 |
Weighted Avg Shares Outstanding | $216.00M | $218.00M | $222.00M | $225.00M |
Weighted Avg Shares Outstanding (Diluted) | $217.00M | $219.00M | $223.00M | $226.00M |
Over the last four quarters, Bath & Body Works, Inc.'s revenue moved from $1.38B in Q1 2024 to $2.79B in Q4 2024. Operating income in Q4 2024 was $678.00M, with a strong operating margin of 24%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Bath & Body Works, Inc. remained robust at $759.00M, reflecting operational efficiency. Net income rose to $453.00M, with an EPS of $2.10. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan